Ala Abudayyeh Selected Research

Renal Cell Carcinoma (Grawitz Tumor)

1/2021	Renal Toxicity.
1/2020	Renal Toxicity.
1/2015	Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ala Abudayyeh Research Topics

Disease

34	Neoplasms (Cancer) 11/2023 - 02/2006
11	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 01/2020
7	Neoplasm Metastasis (Metastasis) 11/2023 - 02/2006
4	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 03/2009
3	Melanoma (Melanoma, Malignant) 10/2023 - 01/2019
3	Nephritis 03/2023 - 01/2020
3	Kidney Diseases (Kidney Disease) 01/2022 - 12/2016
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2015
3	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2021 - 01/2019
3	Glomerulonephritis 01/2021 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 09/2021
2	Myositis (Idiopathic Inflammatory Myopathies) 10/2023 - 01/2023
2	Colitis 10/2023 - 01/2023
2	Vasculitis (Vasculitides) 01/2023 - 01/2020
2	Thrombotic Microangiopathies 11/2022 - 01/2022
2	Lung Neoplasms (Lung Cancer) 10/2022 - 02/2011
2	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 01/2022
2	Cholangiocarcinoma 01/2022 - 01/2022
2	Hemorrhagic Cystitis 01/2021 - 02/2017
2	Chronic Renal Insufficiency 01/2021 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 10/2020
2	Multiple Myeloma 12/2020 - 01/2017
2	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2020 - 01/2019
2	Primary Myelofibrosis (Myelosclerosis) 07/2019 - 08/2015
2	Carcinogenesis 01/2017 - 06/2012
2	Esophageal Neoplasms (Esophageal Cancer) 06/2012 - 07/2009
2	Colonic Neoplasms (Colon Cancer) 10/2009 - 07/2008
1	Lupus Nephritis 05/2024
1	Diabetes Mellitus 01/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Urogenital Neoplasms 10/2023
1	Residual Neoplasm 02/2023
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Central Nervous System Vasculitis 01/2023
1	Critical Illness (Critically Ill) 01/2023
1	Myocarditis (Carditis) 01/2023
1	Hepatitis 01/2023
1	Cholangitis 01/2023
1	Arthritis (Polyarthritis) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Myasthenia Gravis 01/2023
1	Paraproteinemias (Monoclonal Gammopathy) 11/2022
1	Klatskin Tumor 01/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021

Drug/Important Bio-Agent (IBA)

13	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2019
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2009
6	cyclopropapyrroloindoleIBA 01/2021 - 01/2019
6	tolfenamic acidIBA 01/2017 - 03/2009
4	Sp Transcription FactorsIBA 10/2014 - 05/2009
3	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 01/2022
3	CreatinineIBA 01/2024 - 01/2020
3	Rituximab (Mabthera)FDA Link 01/2023 - 01/2020
3	SurvivinIBA 01/2017 - 03/2009
2	Circulating Tumor DNAIBA 11/2023 - 02/2023
2	Infliximab (Remicade)FDA Link 10/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 02/2023 - 01/2017
2	pembrolizumabIBA 10/2022 - 01/2021
2	LigandsIBA 03/2022 - 03/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2020
2	Gemcitabine FDA Link 01/2022 - 01/2022
2	SteroidsIBA 01/2020 - 01/2019
2	ruxolitinibIBA 07/2019 - 08/2015
2	Antineoplastic Agents (Antineoplastics)IBA 10/2014 - 10/2009
2	Proto-Oncogene Proteins c-metIBA 02/2011 - 07/2009
2	Messenger RNA (mRNA)IBA 10/2009 - 03/2009
1	Serum AlbuminIBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 01/2024
1	MagnesiumIBA 01/2024
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2023
1	AntibodiesIBA 01/2023
1	durvalumabIBA 01/2023
1	Amikacin (A.M.K)FDA LinkGeneric 01/2023
1	AminoglycosidesIBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 11/2022
1	Complement System Proteins (Complement)IBA 11/2022
1	Programmed Cell Death 1 ReceptorIBA 03/2022
1	Vascular Endothelial Growth FactorsIBA 01/2022
1	CalcineurinIBA 01/2022
1	atezolizumabIBA 01/2021
1	AntigensIBA 01/2021
1	NivolumabIBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021

Therapy/Procedure

15	Therapeutics 05/2024 - 08/2015
9	Immunotherapy 11/2023 - 01/2020
6	Liver Transplantation 11/2023 - 01/2019
5	Drug Therapy (Chemotherapy) 11/2022 - 02/2006
4	Transplantation 11/2023 - 01/2021
4	Hematopoietic Stem Cell Transplantation 01/2022 - 08/2015
2	Neoadjuvant Therapy 01/2022 - 01/2022
2	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 01/2022
2	Organ Transplantation 06/2019 - 01/2019
1	Palliative Care (Palliative Therapy) 11/2023
1	Continuous Renal Replacement Therapy 01/2023
1	Radiofrequency Ablation 03/2022
1	Duration of Therapy 01/2022